不良研究所

The teaching hospital network of 不良研究所 is an integral part of the research, teaching, and clinical activities of the Faculty of Medicine and Health Sciences. By agreement and tradition, the administration, medical staff, and scientific personnel of these institutions are closely integrated with 不良研究所 and form the basis for the clinical departments of the Faculty of Medicine and Health Sciences. The 不良研究所 Health Centre (MUHC) / Centre universitaire de sant茅 不良研究所 (CUSM) is a merger of seven teaching hospitals affiliated with the Faculty of Medicine and Health Sciences at 不良研究所. The activities of the MUHC are carried out at the following locations*:

• Montreal Children's Hospital, Royal Victoria Hospital, Montreal Chest Institute, and Cedars Cancer Centre at the Glen Site
• 1001 Decarie Boulevard
• Montreal QC H4A 3J1
• Telephone: 514-934-1934
• Website:

• Montreal General Hospital
• 1650 Cedar Avenue
• Montreal QC H3G 1A4
• Telephone: 514-934-1934
• Website:

• Montreal Neurological Institute and Hospital
• 3801 University Street
• Montreal QC H3A 2B4
• Telephone: 514-398-6644
• Website:

• Lachine Hospital
• 650 16th Avenue
• Lachine QC H8S 3N5
• Telephone: 514-934-1934
• Website:

The 不良研究所 Health Centre (MUHC), located in Montreal, is one of the most innovative academic health centres in North America. Building on the tradition of medical leadership of its founding hospitals and focusing on complex care, the MUHC receives more than 513,000 ambulatory visits, admits over 36,000 in-patients, performs more than 30,000 surgeries and delivers almost 3,000 babies yearly. In addition to its clinical expertise, the MUHC is proud of the quality and rigour of its clinical and scientific training. Each year 1,200 research trainees; 910 residents, pharmacists and dentists; 2,150 nursing students, nursing assistants, patient attendants, and paramedics; and 730 medical students are trained. Continuing education programs are also an integral part of delivering excellent patient care. In addition, all MUHC physicians are appointed professors at the Faculty of Medicine and Health Sciences at 不良研究所.

The 不良研究所 Health Centre (MUHC) is one of the world鈥檚 foremost academic health centres. Affiliated with the Faculty of Medicine and Health Sciences of 不良研究所, the MUHC continues to shape the course of adult and pediatric medicine by attracting clinical and research expertise from around the world, assessing the latest in medical technology and training the next generation of medical professionals. In collaboration with our network partners, we are building a better future for our patients and their families; for our employees, professionals, researchers, and students; for our community and above all, for life.

The MUHC has more than 14,400 healthcare and other personnel working within the organization's seven clinical missions:

• The Montreal Children's Hospital
• Medicine
• Surgery
• Neurosciences
• Mental Health
• Women's Health
• Cancer Care

The Research Institute of the 不良研究所 Health Centre (RI-MUHC) is a world-renowned biomedical and healthcare research centre. The Institute, which is affiliated with the Faculty of Medicine and Health Sciences of 不良研究所, supports close to 460 researchers and nearly 1,200 research trainees devoted to a broad spectrum of fundamental, clinical, and evaluative research at the Glen site and the Montreal General Hospital. Its research facilities offer a dynamic multidisciplinary environment that fosters collaboration and leverages discovery aimed at improving the health of individual patients across their lifespan.

The RI-MUHC is supported in part by the Fonds de recherche du Qu茅bec 鈥� Sant茅 (FRQS). More information is available at .

In 2015, the MUHC brought together our legacy sites 鈥� the Montreal Chest Institute, the Royal Victoria Hospital, the Montreal Children's Hospital, and the Cedars Cancer Centre 鈥� onto one site: the Glen. At the Glen site, our vision of excellence is taking shape by integrating healthcare, research, and teaching

on a whole new level. With custom-built facilities, state-of-the-art equipment, and nurturing healing environments, we are pushing the boundaries of innovation for our current generation and those to come. Renovations are also underway at our other MUHC sites 鈥� the Lachine Hospital, the Montreal General Hospital, and the Montreal Neurological Hospital 鈥� as we continue to strive to provide the best care for life for our patients and families.

For more information on the MUHC, visit .

There are three other principal teaching hospitals:

Jewish General Hospital (a member facility of the Integrated Health and Social Services University Network for West-Central Montreal/Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS) du Centre-Ouest-de-l'脦le-de-Montr茅al)

• 3755 C么te Ste-Catherine Road
• Montreal QC H3T 1E2
• Telephone: 514-340-8222
• Website:

Since 1934, the Jewish General Hospital has served patients of diverse religious, linguistic and cultural backgrounds who reside in Montreal, elsewhere in Quebec, and beyond. As one of the province's largest acute-care hospitals, this 637-bed 不良研究所 teaching hospital admits more than 25,000 patients per year, while handling approximately 520,000 outpatient visits, more than 86,000 emergency visits, and more than 3,900 births. The JGH is widely recognized for excellence in various specialties, including oncology at the Segal Cancer Centre, cardiology, neonatology, orthopedics, family medicine, aging, and emergency medicine. In addition, several services鈥攊ncluding the Emergency Department, Intensive Care, Neonatal Intensive Care, Coronary Care, and the operating rooms鈥攐pened in a new critical-care pavilion in 2016. The hospital has been designated by the government of Quebec as one of Montreal's five major service centres; as a provincial centre for high-risk obstetrical and neonatal care; and as a breast referral and investigation centre. In addition, during the COVID-19 pandemic, the JGH played a leading role in treatment and care, having been designated by the provincial government in early 2020 as one of the first healthcare centres to provide in-patient treatment to adults who were ill with the virus.

Treatment is provided by approximately 700 affiliated doctors, many of whom have teaching appointments at 不良研究所, as well as 300 medical residents per year, together with nursing and a wide range of allied health services. The Jewish General Hospital carries out more than 22% of the training for 不良研究所's Faculty of Medicine and Health Sciences and is home to several of the University's programs, including the 不良研究所 Centre for Viral Diseases (encompassing research formerly conducted by the 不良研究所 AIDS Centre), the 不良研究所 Centre for Translational Research in Cancer, the 不良研究所 Head and Neck Surgery and Oncology Program, and the 不良研究所 Menopause Clinic. The hospital's Lady Davis Institute is acknowledged as a world leader in many fields of research, including cancer (the Terry Fox Molecular Oncology Group), aging (the Bloomfield Centre for Studies in Aging), epidemiology (the Centre for Clinical Epidemiology and Community Studies), nursing (the Centre for Nursing Research), cardiovascular disease, genetics, emergency medicine, nephrology, and the psychosocial aspects of illness. The outstanding quality of this work has enabled the Lady Davis Institute to rank among the leaders of Quebec鈥檚 hospital-affiliated research institutions in attracting high levels of funding per researcher.

More information is available at .

St. Mary's Hospital Center (Montreal West Island Integrated University Health and Social Services Centre/Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS) de l'Ouest-de-l'脦le-de-Montr茅al)

• 3830 Lacombe Avenue
• Montreal QC H3T 1M5
• Telephone: 514-345-3511
• Website:

St. Mary's Hospital Center (SMHC) is an acute-care specialized 不良研究所 affiliated teaching hospital with 271 adult beds. Its official designation as a university-affiliated teaching hospital or a CHAU (Centre hospitalier affili茅 universitaire) further reinforces its commitment and ability to deliver high quality health care while playing a leading role in the areas of teaching and research. It is responsible for the training of a large cohort of undergraduate and post-graduate students in Medicine and the allied health disciplines.

Over 3,600 babies are delivered annually at St. Mary's, which is the first hospital in Montreal to have received the World Health Organization's (WHO) international recognition of Baby Friendly Hospital Status by the Quebec ministry of health. St. Mary's also has a progressive and active Family Medicine Centre recognized for its teaching. The Hospital also provides numerous highly specialized services such as renal dialysis, oncology, geriatric assessment, and psycho-geriatric, nuclear medicine, C.T. scanning services, as well as MRI exams. There are more than 120,000 out-patient clinic visits, 10,000 procedures through the surgical day centre, and over 11,000 patient admissions, in addition to ambulatory care visits, annually.

The Hospital is noted for its devotion to patients, motivation toward the achievement of excellence, and compassionate care.

Visit the St. Mary's Hospital Center website at to learn more.

Douglas Mental Health University Institute (Montreal West Island Integrated University Health and Social Services Centre/Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS) de l'Ouest-de-l'脦le-de-Montr茅al)

• 6875 LaSalle Boulevard
• Montreal QC H4H 1R3
• Telephone: 514-761-6131
• Website:

Founded in 1881, the Douglas Mental Health University Institute has a triple mission of care, research, and teaching. A member of the 不良研究所 Integrated University Health and Social Services Network (RUISSS 不良研究所) and affiliated with the World Health Organization, it offers hospitalization and extensive out-patient services.

The hospital provides child and adolescent, adult, and geriatric clinical services, and is dedicated to treating patients in the least restrictive manner possible, with a major focus on rehabilitation and successful reintegration into the community. It offers training for residents in psychiatry, as well as for medical and paramedical students from a wide range of disciplines.

The Douglas Institute is one of the largest research centres in mental health in the country, with a team of more than 60 scientists and clinical researchers and more than 200 university students. This team is devoted to making better sense of the causes of mental disorders 鈥� whether genetic, environmental, cultural, or social 鈥� as well as developing diagnostic tools, treatments, and prevention methods. The Douglas Hospital Research Centre is also home to 不良研究所 centres in schizophrenia, aging, and suicide, as well as the Montreal Pan American Health Organization/World Health Organization Collaborating Centre for Reference and Training in Mental Health, which offers consultation services, research, and teaching programs here and abroad.

Visit the Douglas Mental Health University Institute website at to learn more.

As part of the Quebec Government鈥檚 health care reform in 2015, most health care institutions merged and grouped into larger entities called either a Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS), or a Centre int茅gr茅 de sant茅 et de services sociaux (CISSS). In general, contracts of affiliation are no longer between individual hospitals and the University but between these larger entities and the University.

The following institutions have contracts of affiliation with 不良研究所 for participation in teaching and research in one or more departments and services:

• 不良研究所 Health Centre

• CIUSSS de l'Ouest-de-l鈥櫭巐e-de-Montr茅al

• CIUSSS du Centre-Ouest-de-l鈥櫭巐e-de-Montr茅al

• CISSS de l'Outaouais

• CISSS de Laval

• Shriners Hospitals for Children - Canada

• Genome Building, Suite 3100
• 740 Doctor Penfield Avenue
• Montreal QC H3A 0G1
• Telephone: 514-398-8975
• Fax: 514-398-8121
• Website:

Pain research at 不良研究所 is carried out by The Alan Edwards Centre for Research on Pain, which comprises researchers from the Faculties of Medicine and Health Sciences, Dentistry, and Science. The main goal of the Centre is to bring together the 不良研究所 community of basic and clinical pain researchers to promote research that will result in novel treatments for chronic pain. Through its own activities and international collaborations, the Centre focuses on new discoveries and their clinical applications that will improve the prevention and management of chronic pain.

• McIntyre Medical Sciences Building, Room 1004
• 3655 Promenade Sir-William-Osler
• Montreal QC H3G 1Y6
• Telephone: 514-398-3512
• Fax: 514-398-7452
• Website:

This centre concentrates on interdisciplinary research on artificial cells first invented here (Chang, 不良研究所,1957, Science 1964) and since evolved into micro-nano systems; nanomedicine; nanobiotherapeutics; nanobiotechnology; nanotechnology; blood substitutes based on nanobiotechnology; hemoperfusion; bioencapsulation of enzymes, cells, stem cells, probiotics; regenerative medicine; delivery systems for drug, enzymes, genes, etc.

At present, the members of this centre at 不良研究所 come from different specialties: Physiology, Biomedical Engineering, Medicine, Pathology, Surgery, Bioengineering, Biotechnology, and Chemical Engineering. This is an international centre with 2 international societies, which coordinates biannual meetings around the world; see . It is the emeritus editor's office for the international journal Artificial Cells, Nanomedicine, and Biotechnology (2020-) and Editor's Office for a book series titled Regenerative Medicine, Artificial Cells, and Nanomedicine. This is a public service website with reviews, papers, videos, and monographs all complementary from the director. It is the major international reference source in this area.

• 3647 Peel Street
• Montreal QC H3A 1X1
• Telephone: 514-398-6033
• Website: mcgill.ca/biomedicalethicsunit

The Biomedical Ethics Unit of 不良研究所, Montreal, was established in 1996 with the aim of supporting scholarly research, clinical services, teaching and public outreach. Members of the unit have backgrounds in sociology, molecular genetics, history, and philosophy with cross-appointments in Social Studies of Medicine, Family Medicine, Experimental Medicine, Human Genetics, Sociology, and the Department of Epidemiology, Biostatistics and Occupational Health.

The BMEU faculty and trainees are active in a variety of interdisciplinary research areas and have expertise in clinical trial methods, research ethics, genetics, reproductive technologies, access to care, public health ethics, health inequalities, biosecurity, anti-aging research, end-of-life care policies, and pharmaceutical development.

We offer a 2-year Master鈥檚 Specialization in Biomedical Ethics through the Departments of Experimental Medicine, Human Genetics, Family Medicine, Philosophy, and Religious Studies.

• 740 Doctor Penfield Avenue, Room 2200
• Montreal QC H3A 1A4
• Telephone: 514-934-1934 ext. 35693
• Fax: 514-398-4020

The Centre for Bone and Periodontal Research was established in October 2001 to promote and facilitate research and training in the areas of bone, cartilage, and periodontal disease. The Bone Centre currently represents the interests of more than 60 clinical and fundamental scientists, many of whom are recognized leaders in research pertaining to disorders such as arthritis, osteoporosis, metastatic and metabolic bone disease, and developmental disorders of the skeleton and oral cavity.

The Centre provides advanced instrumentation for hard tissue research, acts to increase the research capacity of its members and to translate advances into improved diagnosis, prevention, and treatment of diseases involving the skeleton and oral cavity.

• 3640 rue de la Montagne
• Montreal QC H3G 2A8
• Telephone: 514-398-6962
• Website:

The Centre for Research on Brain, Language and Music (CRBLM) at 不良研究所 is a Regroupement Strat茅gique whose mission is to promote research and training in the areas of language and music neuroscience, performance, and development. Participating universities include 不良研究所, Universit茅 de Montr茅al, UQAM, and Concordia. Our infrastructure for language and music research is unparalleled, including research facilities located in the 不良研究所 Faculties of Medicine and Health Sciences, Science, Arts, and Education, as well as the International Laboratory for Brain and Music Research (BRAMS) located at the Universit茅 de Montr茅al. Our specific objectives include:

1. promoting the scientific study of language and music neuroscience, performance, and development;
2. stimulating interdisciplinary and cross-domain collaboration among researchers on basic and applied problems in language and music;
3. fostering innovative research training for graduate and postdoctoral students;
4. disseminating research findings to clinical and educational end-users;
5. forming national and international partnerships.

Our goal is to develop a fundamental theoretical, behavioral, and neuroscientific understanding of the neurobiological, social, and communicative processes of language and music.

• The Research Institute, MUHC Glen Site
• 1001 Decarie Blvd.,E-M0.3509
• Montreal QC H4A 3J1
• Telephone: 514-207-9887
• Website: mcgill.ca/crrd

The Centre for Research in Reproduction and Development (CRRD), originally established as the Centre for the Study of Reproduction in 1982, is among the longest-standing research centres at 不良研究所 and was a founding partner of the FQRNT-funded R茅seau Qu茅becois en Reproduction (RQR). Today, the interdepartmental and interdisciplinary CRRD is home to more than 30 principal investigators, 70 graduate students, 50 fellows and research associates, and 30 technical support staff from 15 departments, 4 faculties, and 8 divisions at the University. With such critical mass, the CRRD has established itself as one of the most productive and dynamic research hubs for young and established researchers committed to the science of reproduction and development.

The research programs of our members span a wide range of diverse and complementary topics, including understanding the basic biological mechanisms that control developing eggs and sperm within the gonads, how the reproductive hormones are produced and exert their effects, how the developing embryo implants into the uterus and establishes communication with its mother, causes and cures for conditions such as pre-eclampsia and intra-uterine growth retardation, and the effects of environmental pollutants and disease on the development of the eggs and sperm and of the fetus. We use both animal model systems and human clinical studies to reach our research objectives.

The CRRD enables and promotes interactions between investigators at 不良研究所, other universities in Quebec, across Canada, and internationally.

• Lady Davis Institute for Medical Research
• Jewish General Hospital
• 3755 C么te Ste-Catherine
• Montreal QC H3T 1E2
• Telephone: 514-340-8222 ext. 28873
• Website: mcgill.ca/translational-research-cancer

The great challenge faced by the oncology research community is in the translation of laboratory and clinical research data into clinical outcomes of benefit in the assessment, treatment and prevention of cancer. Established in 1996, thanks to a generous endowment gift from the Goldfarb Family Foundation and the Alexander Family Foundation, the MCTRC aims to facilitate the translation of the exciting novel findings made in fundamental laboratories into testable hypotheses for evaluation in clinical trials in oncology (bench-to bedside translation). The Centre provides the infrastructure to bring fundamental and clinician researchers together in order to synergize their efforts at generating novel and promising translational research. This provides a structured focus for these activities and accelerates the testing of potential benefits derived from scientific discovery. Over the years, the MCTRC researchers have been key in discovering, testing and translating new treatment options and diagnostic markers that leads to new cancer management guidelines, and improving cancer care to Canadians.

The Centre provides a high quality environment for training clinician-scientists in cancer research. Trainees include both graduate students (M.Sc. and Ph.D. students) from the departments of Experimental Medicine, Human Genetics, Pharmacology & Therapeutics, and Pathology) and M.D. scientists interested in clinically-relevant cancer research.

The unique interaction of clinician-scientists and Ph.D. researchers provides an important strength to novel therapeutic development programs. As part of the Segal Cancer Centre located at the Jewish General Hospital, the MCTRC has been forging partnerships with other provincial (iTMT, QCC, Q-CROC) national (Exactis) and international (CCC19 and WIN Consortia) research groups as part of its commitment to conducting cutting-edge fundamental, translational and clinical research in cancer and providing training for the next generation of cancer researchers.

• Email: info [at] ludmercentre.ca
• Website:

The Ludmer Centre for Neuroinformatics & Mental Health advances multi-omics, big-data research in normal and abnormal brain development鈥攏eurological and psychiatric. It is a collaboration between 不良研究所, the Douglas Mental Health University Institute (The Douglas), the Jewish General Hospital鈥檚 Lady Davis Institute (JGH/LDI), and Montreal Neurological Institute-Hospital (The Neuro).

The Centre encompasses 13 researchers, their labs and trainees, based in the faculties of Science and Medicine and Health Sciences, 4 hospitals (The Douglas, JGH, The Neuro, MUHC) and 3 universities (不良研究所, Concordia, Yale), and

• Develops innovative, interoperable and open-source neuroinformatics infrastructure.
• Leads and supports the application of largescale big-data approaches to brain research.
• Mentors and trains transdisciplinary researchers in the application of big-data research.

  leads the Neuroimaging and Neuroinformatics Pillars (the 不良研究所 Centre for Integrative Neuroscience-MCIN) at The Neuro. A James 不良研究所 Professor of Neurology & Neurosurgery, he is the Scientific Director of three 不良研究所-led transdisciplinary initiatives: the , , and Healthy Brains, Healthy Lives.

  leads the Genomics, Bioinformatics & Statistical Genetics Pillar. She is a James 不良研究所 Professor in the departments of Oncology, Human Genetics & Epidemiology; Biostatistics & Occupational Health; and the Division of Cancer Epidemiology; and the Graduate Program Director of the Ludmer-supported Quantitative Life Sciences (QLS) PhD program at 不良研究所.

  leads the Genomic & Epigenetics Pillar. She is an Assistant Professor in the Department of Psychiatry at 不良研究所 and Leads the Environmental Adversity, Neurodevelopment and Mental Health research group at the Douglas Mental Health University Institute. Dr Silveira is a member of the National Scientific Council on the Developing Child at the Harvard School of Medicine.

To learn more, or participate in a.

• Lady Davis Institute, Room F-318
• Jewish General Hospital
• 3999 C么te Ste-Catherine
• Montreal QC H3T 1E2
• Telephone: 514-340-8260
• Contact: mcvd [at] mcgill.ca
• Website: mcgill.ca/mcvd/

Established in 1990 under the direction of the late Dr. Mark Wainberg, the 不良研究所 AIDS Centre has been at the forefront of HIV research. Now, it is transformed into the 不良研究所 Centre for Viral Diseases, marking its evolution to the study of other viruses that pose serious threats to global health.

The process to formalize expansion of the Centre and redefine its mission to provide solutions to all viral diseases that threaten public health began in 2017. Its scientists have built research programs in areas such as basic virology, immunology, drug discovery, epidemiology, population studies and clinical research.

Dr. Chen Liang is the Centre鈥檚 Acting Director. He is an internationally renowned HIV researcher whose lab specializes in restriction factors (RFs), innate anti-viral proteins that are the body鈥檚 first-line defence against viruses. Dr. Liang discovered two of the few known host RFs, which underpin the key innate anti-HIV-1 mechanisms. He also pioneered the study of using the genome editor CRISPR to cure HIV infection. Dr. Liang also played an integral role in launching 不良研究所鈥檚 two containment level-3 labs for COVID research.

Many members of the Centre have benefited from the support of MI4 through funding and collaboration. With this diverse and interdisciplinary environment, we are better positioned to find solutions to the COVID-19 pandemic.

• Montreal General Hospital, Livingston Hall, L7 132
• Research Institute of the 不良研究所 Health Centre
• 1650 Cedar Avenue
• Montreal QC H3G 1A4
• Telephone: 514-934-8094
• Fax: 514-934-8216
• Website: mcgill.ca/crn

The 不良研究所 Centre for Research in Neuroscience (CRN), which was officially established as a University Centre in 1986 under the leadership of Dr. Albert Aguayo, is a vibrant research centre that brings together basic and clinical scientists in highly interactive research groups.

With construction of new CRN laboratories in 1993 and continued expansion since, the group has broadened its focus to include research into the development of neural tissues, synapse formation, and plasticity, the assembly and function of neural circuits, and behavior, while maintaining its strengths in regeneration and repair.

The CRN has been and remains home to some of Canada鈥檚 most distinguished neuroscientists. We number more than 60 trainees and staff at any time, including postdoctoral researchers, graduate students, undergraduates, and technicians. The CRN offers a program to train pre-doctoral students for an M.Sc. or Ph.D. degree, as well as postdoctoral Ph.D. or M.D. graduates for careers in biomedical research.

• Research Institute of the 不良研究所 Health Centre
• 5252 de Maisonneuve West, Room 3D.58
• Montreal, Quebec, Canada
• H4A 3S5
• Telephone: 514-934-1934, ext. 32128
• Fax: 514-484-1424
• Website: mcgill.ca/tb

The 不良研究所 International TB Centre, a WHO Collaborating Centre for TB Research, is a world leader in the interdisciplinary study of TB. Our Centre brings together more than 20 investigators based at 不良研究所 as well as the Research Institute of the MUHC, with expertise in biomedical, clinical, epidemiologic, and social aspects of TB. We work to better understand TB pathogenesis and host resistance, and also develop and evaluate new diagnostics, vaccines, and treatment regimens for the control of TB. By means of quality training, technical assistance, capacity building, and policy-relevant research, our Centre aims to make a positive contribution to ending the TB epidemic nationally as well as globally. Please visit our website at mcgill.ca/tb.

• 6825 boulevard LaSalle
• Verdun QC H4H 1R3
• Telephone: 514-766-2010
• Website:

The 不良研究所 Research Centre for Studies in Aging (MCSA) is committed to investigating causes and possible treatments of the dementias, especially Alzheimer's Disease. Established in 1985 to develop and offer specialized services for the elderly, MCSA has grown into a multi-disciplinary academic unit dedicated to gerontological research and postgraduate teaching. The MCSA research scope is broad, encompassing mechanisms of aging as well as prevention of age-associated disorders. Since its inception, the MCSA remains dedicated to transformative research and counts numerous teaching, public education, and research accomplishments. The Centre has achieved international recognition and outreach, continuously attracting students, young scientists and international collaborators in Alzheimer鈥檚 Disease research. The Center鈥檚 scientific production and visibility through many highly cited contributions attest to its excellence and world-class research positioning.

During the past decades, the MCSA has played a pioneering role in identifying genetic abnormalities leading to an increased risk for Alzheimer's Disease. The Memory Clinic of the Alzheimer's Disease Research Unit, under the leadership of Dr. Serge Gauthier, is focusing on improved therapies, long-term treatment of subjects affected by dementia, and enhancing the quality of life of patients and caregivers. Over the last 35 years the priority of the MCSA evolved to primary prevention of cognitive decline, early diagnosis, and treatment for persons with mild or prodromal symptoms, and best treatments for patients with various types of dementia. The importance of genes such as ApoE as risk factors and as predictors of response to treatment in Alzheimer鈥檚 Disease was one of the significant contributions of the MCSA to the field of aging. Another achievement of the MCSA is the strong link with academic research centres around the world, including Brazil, China, and Germany, which is reflected by a steady flow of students and visiting scholars from these countries, among others.

In Canada, the MCSA created the academic trial network C5R and has hosted consensus meetings on the best evidence-based approach to the diagnosis and management of various types of dementia. The current focus of the MCSA is on prevention, and the development of tools and methods to allow earliest diagnosis and intervention of age-related disease. Prevention has been identified as an important objective in dementia research by national and international institutes (Alzheimer Society of Canada, National Institute of Aging USA) and is a priority of 不良研究所 over the next decade. The MCSA contributes to this effort with its Dementia Prevention Program that was launched in 2012, entitled 鈥淧revention of Neurodegenerative Disease in Everyone at Risk鈥� (P.O.N.D.E.R.). This program was rebranded in 2020 and is now called SNAP, 鈥淪creening of Neurobehavioural Abnormalities in the Aging Population.鈥� SNAP, aims to characterize both normal aging and disease, as well as risk and protective factors. SNAP still aims at utilizing cognitive performance as a tool to screen for dementia at early stages. SNAP features a website that provides free online cognitive assessments and encompasses a comprehensive approach towards the study of variables associated with neurodegeneration in the elderly population. The website is currently available for participants! To register and play the free cognitive training games please visit:

The MCSA has established a computational infrastructure devoted for teaching neuroimaging in dementia for fellows, graduate, and postdoctoral students. This infrastructure program is under the direction of Dr. Pedro Rosa-Neto, M.D., Ph.D. The Translational Neuroimaging Laboratory at the MCSA aims to understand how toxic proteins cause brain damage in Alzheimer鈥檚 disease patients. We also develop novel methodologies for early detection of these toxic proteins in the persons without symptoms (see the ). Research in the field of neuroimaging has been focusing on the early detection of dementia, and AD prevention. Our clinic collaborates with other experts at 不良研究所 using the most advanced and sensitive Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) protocols to evaluate patients with mild cognitive complaints. The PET and MRI technologies, combined with our clinical expertise, allow for early diagnosis and appropriate treatment of the condition causing memory deficits.

• 1160 Pine Avenue West
• Montreal QC H3A 1A3
• Telephone: 514-398-3535
• Fax: 514-398-6769
• Website: mcgill.ca/gcrc

The mission of the Rosalind and Morris Goodman Cancer Research Centre is to bring together internationally renowned scientists who are devoted to cancer research and provide them with state-of-the-art resources so that they can fully contribute to the worldwide effort of developing novel approaches for the improvement of the diagnosis, treatment, and management of this disease. Investigators within the Centre have made significant contributions toward the molecular understanding of diseases such as cancer which can be exploited to better stratify cancer and facilitate the development of novel therapeutic approaches.

The Rosalind and Morris Goodman Cancer Research Centre provides an internationally recognized training ground for the next generation of investigators who will pursue research in the life sciences and cancer. The Centre plays a key role in reaching out and educating the public on the fundamentals of cancer research and understanding the causes of cancer, its prognosis, and its treatment.

Further information is available at Rosalind and Morris Goodman Cancer Research Centre.

• Charles Meredith House
• 1130 Pine Avenue West
• Montreal QC H3A 1A3
• Telephone: 514-398-1236
• Website: mcgill.ca/ihsp

The Institute for Health and Social Policy is a tri-faculty Institute of the Faculties of Medicine and Health Sciences, Arts, and Law, and a unit of the 不良研究所 School for Population and Global Health. It is a multidisciplinary institute for research, training, and cross-sectoral collaboration on issues of social policy, health, and well-being. Its activities focus on how policy is formulated and implemented across different contexts, and on how policy affects population health and well-being. The Institute aims to bring normative and empirical perspectives together in support of effective social policy.

The 不良研究所 Institute for Health and Social Policy is as a multidisciplinary centre for research, training and dialogue on issues of health and social policy. The IHSP conducts world-class research on how social conditions impact the health, well-being and resilience of people and communities locally, provincially, nationally and globally. The Institute collaborates across sectors and disciplines, bringing values and evidence together in support of healthy social policy.

Since it was founded, the Institute for Health and Social Policy has supported numerous world-class initiatives investigating how social conditions impact population health and welfare. For more information, visit: the IHSP website.

• Lady Meredith House
• 1110 Pine Avenue West, Room 205
• Montreal QC H3A 1A3
• Telephone: 514-398-4987
• Fax: 514-398-7246
• Website: mcgill.ca/ihse

The Institute of Health Sciences Education (IHSE) was created in February 2019. Building on the success of the Centre for Medical Education, the new Institute promotes excellence and scholarship across the continuum of health sciences education. More specifically, the IHSE at 不良研究所:

• Conducts research and scholarly work in health sciences education;
• Ensures that research advances the field of health sciences education and informs educational practice;
• Supports interest in educational research and development;
• Encourages innovation and excellence in teaching and learning; and
• Offers educational programs and capacity building for future leaders in health sciences education.

With an active interest in the development and enhancement of health sciences education and practice, members of the IHSE consist of clinicians, educators, and researchers from diverse backgrounds and disciplines. Bringing together research and practice, this unique mix of individuals will help us to move beyond traditional departmental and disciplinary boundaries to create new knowledge, enable capacity-building, and promote knowledge translation in the field.

The Institute of Health Sciences Education offers a variety of educational opportunities to students, residents, and faculty. Of interest to medical students and residents are:

1. The Scholarship in MedEd and Health Sciences Education program, designed for medical students and residents who view education as part of their career. Participants will develop a scholarly project in MedEd and HSE, and apply medical education theories and/or principles pertinent to their project. For more information, visit: the Institute of Health Sciences Education's website.
2. The Foundations in MedEd and Health Sciences Education program, a non-clinical elective offered on an annual basis in Period 6 of the rotation schedule, which generally falls between November-December of the calendar year. The elective is intended to expose students and residents to the field of medical education through interactive lectures, group discussions, individual and group projects, and participation in the activities of the Institute of Health Sciences Education. For more information, visit: the IHSE website.

• 3801 University Street
• Montreal, Quebec, Canada H3A 2B4
• Telephone: 514-398-6644
• Website: mcgill.ca/neuro

The Neuro (Montreal Neurological Institute-Hospital) is a world-leading destination for brain research, training and advanced patient care. The Montreal Neurological Institute is a 不良研究所 research and teaching institute. The Montreal Neurological Hospital is part of the Neuroscience Mission of the 不良研究所 Health Centre.

Founded in 1934 by neurosurgeon Dr. Wilder Penfield, The Neuro is the largest specialized neuroscience research and clinical centre in Canada, and one of the largest in the world and the first institute in the world to adopt fully an Open Science philosophy. Our mission is to understand the brain, find cures and effectively treat people with neurological disorders. Our vision is to transform neurological research and care to change lives.

The Neuro鈥檚 scientists and clinicians are pushing the frontiers of science and medicine. They have pioneered surgical treatments of epilepsy and developed electroencephalography as a tool to diagnose seizure activity. The Neuro is the home of many famous neuroscientists including Brenda Milner, Herbert Jasper, KAC Elliot, George Karpati and many others. Scientists in The Neuro鈥檚 McConnell Brain Imaging Centre (BIC) introduced Computer Tomography (CT), Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Canada. In February 2019, The Neuro became home to Canada鈥檚 first whole body 7T MRI.

The Neuro strives to adopt the newest technologies and recruit the best scientists, trained at the world鈥檚 leading research centres. It is now at the very vanguard of the future of brain science: transparent, fast and global flow of knowledge, where discoveries made on one continent can instantly amplify those on another, and where patients benefit from discoveries that represent the most advanced research taking place around the world.

The Neuro is the largest training centre for Neuroscience in Canada, with over 250 postdoctoral fellows, residents, and graduate students working in the labs and clinics each year.

Neuro faculty members are collaborative and lead international research teams that generate fundamental information that spans the full spectrum of neuroscience from cell and molecular biology and neurophysiology to brain imaging and cognitive neuroscience to big data and artificial intelligence.

• Brain Tumour
• Cognitive Neuroscience
• Epilepsy
• Neural Circuits
• Neurodegenerative Disorders
• Neurodevelopmental Disorders
• Neuroimaging and Neuroinformatics
• Neuroimmunological Diseases
• Rare Neurological Diseases

For more information, please visit www.theneuro.ca